PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 198 filers reported holding PDL BIOPHARMA INC in Q1 2016. The put-call ratio across all filers is 1.70 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $8,893,000 | -0.2% | 2,670,761 | +7.2% | 0.02% | 0.0% |
| Q4 2015 | $8,908,000 | -29.5% | 2,491,781 | -0.8% | 0.02% | -33.3% |
| Q3 2015 | $12,633,000 | +37.6% | 2,511,507 | +75.9% | 0.02% | +60.0% |
| Q2 2015 | $9,181,000 | -31.0% | 1,427,935 | -24.5% | 0.02% | -37.5% |
| Q1 2015 | $13,298,000 | -1.8% | 1,890,287 | +7.7% | 0.02% | 0.0% |
| Q4 2014 | $13,535,000 | -6.4% | 1,755,580 | -9.3% | 0.02% | -7.7% |
| Q3 2014 | $14,461,000 | -30.3% | 1,936,010 | -9.7% | 0.03% | -27.8% |
| Q2 2014 | $20,751,000 | +18.6% | 2,143,851 | +1.8% | 0.04% | +16.1% |
| Q1 2014 | $17,498,000 | -6.2% | 2,105,449 | +2.6% | 0.03% | -8.8% |
| Q4 2013 | $18,652,000 | +10.0% | 2,053,039 | -3.5% | 0.03% | +13.3% |
| Q3 2013 | $16,952,000 | +5.1% | 2,126,954 | +1.8% | 0.03% | 0.0% |
| Q2 2013 | $16,128,000 | – | 2,089,055 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |